Therapeutic Drug Monitoring of Tigecycline in 67 Infected Patients and a Population Pharmacokinetics/Microbiological Evaluation of A. baumannii Study
BackgroundThe widespread use of antibiotics has led to the emergence of multidrug-resistant (MDR) bacteria such as multidrug-resistant Acinetobacter baumannii (AB). Tigecycline (TGC), as the first glycylcycline antibiotic approved by FDA, is a broad-spectrum antibiotic which remains highly effective...
Main Authors: | Tianli Yang, Hekun Mei, Jin Wang, Yun Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.678165/full |
Similar Items
-
Comparison of minimal inhibitory concentrations (MICs) of tigecycline in 2011 and 2015 years against multidrug-resistance acinetobacter baumannii strains
by: Yucel Duman, et al.
Published: (2017-03-01) -
Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
by: Jiawei Zeng, et al.
Published: (2017-08-01) -
In vitro activity of tigecycline against clinical isolates of carbapenem resistant <it>Acinetobacter baumannii</it> complex in Pretoria, South Africa
by: Ahmed Nahid H, et al.
Published: (2012-05-01) -
Relative Gene Expression of RND-Type Efflux Pumps in Tigecycline Resistant Acinetobacter Baumannii Isolated from Training Hospitals in Tehran, Iran
by: Mina Owrang, et al.
Published: (2018-12-01) -
The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
by: Liping Li, et al.
Published: (2020-10-01)